Inventor · disambiguated record
Katsumasa Nakajima
Also filed as: NAKAJIMA KATSUMASA
7 granted patents·11 pending applications·18 citations·filing 2006–2025
78Inventor score
Top patents by PatentIndex Score
18 records- 0182US8703761B2Organic compoundsFORSTER CORNELIA JUTTA·Filed 2009·Granted Apr 22, 2014·11 cites·14 claims
- 0277US11958846B2Urea compounds and compositions as SMARCA2/BRM ATPase inhibitorsNOVARTIS AG·Filed 2019·Granted Apr 16, 2024·2 cites·11 claims
- 0376US12358906B2Urea compounds and compositions as SMARCA2/BRM ATPase inhibitorsNOVARTIS AG·Filed 2024·Granted Jul 15, 2025·0 cites·13 claims
- 0475US7700633B2Organic compoundsNOVARTIS AG·Filed 2006·Granted Apr 20, 2010·3 cites·33 claims
- 0573US11970497B2Tricyclic AKR1C3 dependent KARS inhibitorsNOVARTIS AG·Filed 2020·Granted Apr 30, 2024·1 cites·22 claims
- 0669US2024262827A1Tricyclic akr1c3 dependent kars inhibitorsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0761US8084448B2Organic compoundsNEUBERT ALAN·Filed 2007·Granted Dec 27, 2011·1 cites·11 claims
- 0860US2025387504A1Antibody-drug conjugates of antineoplastic compounds and methods of use thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0958US2025179063A2Selective bcl-xl protac compounds and methods of useHERNER ANDRAS·Filed 2022·Application pending·0 cites
- 1058US2025179072A1Tricyclic akr1c3 dependent kars inhibitorsNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1158US2024376094A2Selective bcl-xl protac compounds and methods of useHERNER ANDRAS·Filed 2022·Application pending·0 cites
- 1257US2023092679A1Mcl-1 inhibitor antibody-drug conjugates and methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1357US2023081720A1Mcl-1 inhibitor antibody-drug conjugates and methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1454US11377656B2Chemically modified messenger RNA'sNOVARTIS AG·Filed 2017·Granted Jul 5, 2022·0 cites·8 claims
- 1553US2024269304A1Bcl-xl inhibitor antibody-drug conjugates and methods of use thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1650US2023091510A1Antibody drug conjugates having linkers comprising hydrophilic groupsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1749US2024042051A1Mcl-1 inhibitor antibody-drug conjugates and methods of useROCCHETTI FRANCESCA·Filed 2021·Application pending·0 cites
- 1842US2008293782A11,1,3-Trioxo-1,2,5-Thiadiazolidines and Their Use as Ptp-Ases InhibitorsBARNES DAVID·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katsumasa Nakajima files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →